Screener
Haemonetics HAE Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 |
|---|---|---|
| Proceeds from exercise of stock options | 426 | 462 |
| Cash used to net share settle employee equity awards | (3,500) | (4,781) |
| Other financing activities | (14) | (36) |
| Net cash used in financing activities | (51,528) | (2,442) |
| Effect of exchange rates on cash and cash equivalents | (617) | 4,182 |
| Net Change in Cash and Cash Equivalents | (22,056) | (13,865) |
| Cash and Cash Equivalents at Beginning of Period | 245,440 | 306,763 |
| Cash and Cash Equivalents at End of Period | $223,384 | $292,898 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's financing cash flow?
- Haemonetics (HAE) reported financing cash flow of -$51.53M in Q2 2026.
- How has Haemonetics's financing cash flow changed year-over-year?
- Haemonetics's financing cash flow decreased by 2010.1% year-over-year, from -$2.44M to -$51.53M.
- What is the long-term trend for Haemonetics's financing cash flow?
- Over 2 years (2022 to 2026), Haemonetics's financing cash flow has grown at a 238.5% compound annual growth rate (CAGR), from -$15.75M to -$180.49M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Haemonetics's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude